+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review

  • ID: 1292308
  • SWOT Analysis
  • October 2019
  • Region: Global
  • 36 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Caliper Life Sciences Inc
  • Elsalys Biotech SA
  • Sigma Life Science
  • Taconic Biosciences Inc
  • MORE
genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
genOway SA (genOway) is a provider of customized genetically-modified (GM) mouse, rat and as well as cellular models for experiments, research, drug development for various therapeutic areas such as cancer, cardiovascular diseases, metabolic Diseases, immunological and neurological disorders. The company applies various technologies such as homologous recombination, Internal Ribosome Entry Site (IRES), nuclease-based gene editing such as CRISPR/Cas9 Gene Editing, Recombinase-Mediated Cassette Exchange (RMCE), TET-On/Off and FLEx to generate its various types of physiologically relevant models. The company provides its services to pharmaceutical/life sciences companies and research institutes and has generated over 2000 genetically-modified (GM) models. genOway is headquartered in Lyon, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Caliper Life Sciences Inc
  • Elsalys Biotech SA
  • Sigma Life Science
  • Taconic Biosciences Inc
  • MORE
Section 1 - About the Company
  • genOway SA - Key Facts
  • genOway SA - Key Employees
  • genOway SA - Key Employee Biographies
  • genOway SA - Major Products and Services
  • genOway SA - History
  • genOway SA - Company Statement
  • genOway SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • genOway SA - Business Description
  • genOway SA - SWOT Analysis
  • SWOT Analysis - Overview
  • genOway SA - Strengths
  • genOway SA - Weaknesses
  • genOway SA - Opportunities
  • genOway SA - Threats
  • genOway SA - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • genOway SA, Recent Deals Summary
Section 5 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • genOway SA, Key Facts
  • genOway SA, Key Employees
  • genOway SA, Key Employee Biographies
  • genOway SA, Major Products and Services
  • genOway SA, History
  • genOway SA, Subsidiaries
  • genOway SA, Key Competitors
  • genOway SA, Ratios based on current share price
  • genOway SA, Annual Ratios
  • genOway SA, Annual Ratios (Cont...1)
  • genOway SA, Annual Ratios (Cont...2)
  • genOway SA, Interim Ratios
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • genOway SA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • genOway SA, Performance Chart (2014 - 2018)
  • genOway SA, Ratio Charts
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • genOway SA, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Transposagen Biopharmaceuticals Inc
  • Taconic Biosciences Inc
  • Sigma Life Science
  • Elsalys Biotech SA
  • Caliper Life Sciences Inc
Note: Product cover images may vary from those shown
Adroll
adroll